Dec 15, 2020 |
Oncocyte to Present at the 15th Annual LD Micro Main Event
|
PDF
|
Dec 15, 2020 |
Oncocyte and Burning Rock Execute Strategic Agreement to Distribute DetermaRx in China
|
PDF
|
Dec 07, 2020 |
Oncocyte Corporation Hosting Key Opinion Leader Call on Proprietary Molecular Tests for Cancer Treatment Selection
|
PDF
|
Nov 18, 2020 |
Oncocyte to Participate at 32nd Annual Piper Sandler Virtual Healthcare Conference
|
PDF
|
Nov 18, 2020 |
Oncocyte Presents New Data on Its DetermaIO™ Test at Association for Molecular Pathology (AMP) 2020 Conference
|
PDF
|
Nov 12, 2020 |
Oncocyte Reports Third Quarter 2020 Financial Results and Provides Corporate Update
|
PDF
|
Nov 09, 2020 |
Oncocyte to Present DetermaIO™ Test Data at the 2020 Society for Immunotherapy of Cancer (SITC) Conference
|
PDF
|
Nov 02, 2020 |
Oncocyte to Report Third Quarter 2020 Financial Results on Thursday, November 12
|
PDF
|
Oct 28, 2020 |
Oncocyte Named One of the 2020 Best Places to Work in Orange County in Its First Year in Irvine, CA
|
PDF
|
Oct 20, 2020 |
Oncocyte Announces Third Quarter Growth of DetermaRx™ Physician Adoption and Testing Volume
|
PDF
|